- Consumers Can Apply for a Chance to Be Featured in Upcoming
Campaigns for BOTOX® Cosmetic, the
JUVÉDERM® Collection of Fillers, and Allē, the Allergan
Aesthetics Loyalty Rewards Program
IRVINE,
Calif., April 23, 2024 /PRNewswire/
-- Allergan Aesthetics, an AbbVie company (NYSE: ABBV),
is offering consumers an opportunity to be featured in upcoming
campaigns for their biggest brands, including BOTOX®
Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē,
the Allergan Aesthetics loyalty rewards program. Beginning today,
consumers—including existing patients and those who are considering
aesthetic treatment—can apply for a chance to be included in future
brand campaigns. The first Allergan Aesthetics open casting call
for BOTOX® Cosmetic elicited approximately 20,000
submissions resulting in a powerful campaign focused on a diverse
set of patients sharing heartfelt, authentic stories for why they
pursued treatment.
"Following the success of our BOTOX® Cosmetic "See
Yourself" campaign we are continuing our commitment to showcasing
natural-looking results that real patients and their providers are
able to achieve with our brands," said Jasson Gilmore, Senior Vice President, U.S.
Aesthetics. "There is nothing more powerful than seeing someone you
can relate to sharing their aesthetic journey. With this casting
call, we are elevating more authentic patient voices while driving
increased diversity across the entire the industry, with the goal
of making this the standard for aesthetics."
Allergan Aesthetics is partnering with Cosmetic Executive Women
(CEW), Black Beauty Roster, Latinas in Beauty, and The Black Beauty
Club to promote the open casting to their members, giving real
patients a platform to share their personal experiences.
"We are seeing a trend towards consumers demanding authenticity
from beauty, cosmetic, and aesthetic companies. Allergan Aesthetics
is the only company we are aware of that is driving that effort in
the aesthetics category, where we feel this level of transparency
and representation is essential," said The Black Beauty Club
co-founders Tomi Talabi and
Asmeret Berhe-Lumax. "We are
thrilled to see a company like Allergan Aesthetics listen to the
voices of our members, and the members of other organizations like
ours, to drive real change in how aesthetic products and
treatments are marketed. We know this authentic approach to
engaging with consumers and reflecting their voices is
essential."
Content from these campaigns will include personal testimonials,
before and after treatment videos and imagery, behind-the-scenes
footage, self-filmed treatment diaries, and a before and after
series for YouTube and other social media platforms.
Allergan Aesthetics open casting call will run through
June 4, 2024, closing at 11:59 p.m. EDT. Anyone interested is encouraged
to apply by submitting their application at
www.alle.com/castingcall. The final cast for each brand will
be announced later this year.
BOTOX® Cosmetic Important Information
APPROVED USES
BOTOX® Cosmetic is a prescription medicine that is
injected into muscles and used to temporarily improve the look of
moderate to severe forehead lines, crow's feet lines, and frown
lines between the eyebrows in adults.
BOTOX® COSMETIC IMPORTANT SAFETY
INFORMATION
BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you
have any of these problems any time (hours to weeks) after
injection of BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to weakening
of associated muscles, can be severe and result in loss of life.
You are at the highest risk if these problems are pre-existing
before injection.
- Swallowing problems may last for several months.
- Spread of toxin effects. The effect of botulinum toxin may
affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as,
or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin
effect when BOTOX® Cosmetic has been used at the
recommended dose to treat frown lines, crow's feet lines, and/or
forehead lines.
BOTOX® Cosmetic may cause loss of strength or general
muscle weakness, vision problems, or dizziness within hours to
weeks of taking BOTOX® Cosmetic. If this happens, do
not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been
reported. They include: itching, rash, red itchy welts,
wheezing, asthma symptoms, or dizziness or feeling faint. Get
medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are
allergic to any of the ingredients in BOTOX® Cosmetic
(see Medication Guide for ingredients); had an allergic reaction to
any other botulinum toxin product such as
Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), or
Xeomin® (incobotulinumtoxinA); have a skin
infection at the planned injection site.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou
Gehrig's disease, myasthenia gravis, or Lambert-Eaton
syndrome, as you may be at increased risk of serious side effects
including difficulty swallowing and difficulty breathing from
typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical conditions,
including: plans to have surgery; had surgery on your
face; have trouble raising your eyebrows; drooping eyelids; any
other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can harm
your unborn baby); are breast-feeding or plan to (it is not known
if BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take, including
prescription and over-the-counter medicines, vitamins, and herbal
supplements. Using BOTOX® Cosmetic with certain
other medicines may cause serious side effects. Do not start any
new medicines until you have told your doctor that you have
received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®,
Dysport®, or Xeomin® in the
past (tell your doctor exactly which product you received); have
recently received an antibiotic by injection; take muscle
relaxants; take an allergy or cold medicine; take a sleep medicine;
take aspirin-like products or blood thinners.
Other side effects of BOTOX® Cosmetic include:
dry mouth; discomfort or pain at the injection site; tiredness;
headache; neck pain; and eye problems: double vision, blurred
vision, decreased eyesight, drooping eyelids and eyebrows, swelling
of your eyelids and dry eyes.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full Product
Information including Boxed Warning and Medication Guide.
JUVÉDERM® Injectable Gel Fillers Important
Information
APPROVED USES
JUVÉDERM® VOLUMA® XC injectable gel is for
deep injection in the cheek area to correct age-related volume
loss, for augmentation of the chin region to improve the chin
profile, and for augmentation of the temple region to improve
moderate to severe temple hollowing in adults over 21.
JUVÉDERM® VOLUX® XC injectable gel is for
deep injection to improve moderate to severe loss of jawline
definition in adults over the age of 21.
JUVÉDERM® VOLLURE® XC,
JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra
XC injectable gels are for injection into the facial tissue for the
correction of moderate to severe facial wrinkles and folds, such as
nasolabial folds. JUVÉDERM® VOLLURE® XC
injectable gel is for adults over 21.
JUVÉDERM® Ultra XC injectable gel is also for
injection into the lips and perioral area for lip augmentation in
adults over 21.
JUVÉDERM® VOLBELLA® XC injectable gel is
for injection into the lips for lip augmentation and correction of
perioral lines, and for injection into the undereye hollows to
improve the appearance of undereye hollows in adults over the age
of 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any
JUVÉDERM® formulation?
Do not use these
products if you have a history of multiple severe allergies or
severe allergic reactions (anaphylaxis), if you are allergic to
lidocaine or the Gram-positive bacterial proteins used in these
products, or if you have had previous allergic reactions to
hyaluronic acid fillers.
What warnings should my doctor advise me about?
- One of the risks with using dermal fillers is the unintentional
injection into a blood vessel. The chances of this happening are
very small, but if it does happen, the complications can be serious
and may be permanent. These complications, which have been reported
for facial injections, can include vision abnormalities, blindness,
stroke, temporary scabs, or permanent scarring of the skin. Most of
these events are irreversible.
- If you have changes in your vision, signs of a stroke
(including sudden difficulty speaking, numbness or weakness in your
face, arms or legs, difficulty walking, face drooping, severe
headache, dizziness, or confusion), white appearance of the skin,
or unusual pain during or shortly after treatment, you should
notify your health care practitioner immediately.
- The use of dermal fillers where skin sores, pimples, rashes,
hives, cysts, or infections are present should be postponed, as
this may delay healing or make skin problems worse.
- The effectiveness of removal of any dermal filler has not been
studied.
What precautions should my doctor advise me about?
- JUVÉDERM® VOLBELLA® XC should only be
injected into undereye hollows by doctors who have completed the
necessary training for this treatment area. To find a doctor, visit
Juvederm.com/find-a-specialist. Doctors who complete the training
will be listed with a symbol
- The safety of these products for use during pregnancy or while
breastfeeding has not been studied
- The safety of JUVÉDERM® VOLUMA® XC has
not been studied in patients under 35 years or over 65 years for
cheek augmentation, under 22 years or over 80 years for chin
augmentation, and under 32 years or over 82 years for temple area
augmentation. The safety of JUVÉDERM® VOLUX®
XC, JUVÉDERM® VOLLURE® XC and
JUVÉDERM® VOLBELLA® XC has not been studied
in patients under 22 years, and the safety of JUVÉDERM®
Ultra Plus XC and JUVÉDERM® Ultra XC has not been
studied in patients under 18 years
- The safety and effectiveness of treatment with
JUVÉDERM® products in anatomical regions outside of
their approved uses have not been established in clinical
studies
- If you have a history of excessive scarring (thick, hard scars)
or pigmentation disorders, treatment in these patients has not been
studied and may result in additional scars or changes in
pigmentation
- If you are planning other procedures including laser treatments
or a chemical peel, there is a possible risk of inflammation at the
treatment site if these procedures are performed closely before or
after JUVÉDERM® injectable gel treatment
- Tell your doctor if you are on therapy used to reduce your
body's natural defense system (such as steroids, chemotherapy, and
medicines to treat autoimmune diseases, HIV, and AIDs), as these
may increase your risk of infection; and medications that can
prolong bleeding (such as aspirin, ibuprofen, or other blood
thinners), as these may result in increased bruising or bleeding at
the injection site.
- Avoid applying makeup for 12 hours after treatment and minimize
strenuous exercise, exposure to extensive sun or heat, and
alcoholic beverages within the first 24 hours following treatment,
as these may cause temporary redness, swelling, and/or itching at
the injection site
- JUVÉDERM® VOLUMA® XC was not studied in
patients with significant loose skin of the chin, neck, or jaw
- The effect of JUVÉDERM® VOLUMA® XC
injection into the chin on facial hair growth has not been
studied
- Patients who experience skin injury near the site of
JUVÉDERM® VOLUMA® XC injection may be at a
higher risk for adverse events
- Tell your doctor if you have already been injected with dermal
fillers in the same area as the one(s) you are about to be treated
for. This information helps your doctor decide when and whether you
should get treatment
What are possible side effects of treatment?
The most
commonly reported side effects with JUVÉDERM® injectable
gels were redness, swelling, pain, tenderness, firmness,
lumps/bumps, bruising, discoloration, and itching. For
JUVÉDERM® VOLBELLA® XC, dryness was also
reported.
These side effects are consistent with other facial injection
procedures and most will resolve within 30 days. Your doctor may
choose to treat side effects persisting longer with antibiotics,
steroids, or hyaluronidase (an enzyme that breaks down hyaluronic
acid).
As with all skin injection procedures, there is a risk of
infection.
To report a side effect with any product in the
JUVÉDERM® Collection, please call the
Allergan® Product Support Department at
1‑877‑345‑5372. Please also visit Juvederm.com or talk to
your doctor for more information.
Products in the JUVÉDERM® Collection are available
only by a licensed physician or properly licensed practitioner.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information,
visit www.allerganaesthetics.com.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines and solutions that solve serious
health issues today and address the medical challenges of tomorrow.
We strive to have a remarkable impact on people's lives across
several key therapeutic areas – immunology, oncology, neuroscience,
and eye care – and products and services in our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X
(formerly Twitter), and YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-invites-consumers-to-be-the-face-of-botox-cosmetic-onabotulinumtoxina-and-their-other-biggest-brands-302123978.html
SOURCE AbbVie